| Bioactivity | Autotaxin-IN-3 is a Autotaxin(ATX) inhibitor with an IC50 of 2.4 nM, compound 33, sourced from patent WO2018212534A1[1]. | ||||||||||||
| Invitro | Autotaxin is an enzyme which is responsible for the increase in lysophosphatidic acid in ascites and plasma, and it is a secretory enzyme important for converting lysophosphatidylchloine (LPC) into lysophosphatidic acid (LPA) as a bioactive signaling molecule[1]. | ||||||||||||
| Name | Autotaxin-IN-3 | ||||||||||||
| CAS | 2156655-68-2 | ||||||||||||
| Formula | C22H21N9O2 | ||||||||||||
| Molar Mass | 443.46 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. LEE, Dae Yon, et al. NOVEL COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. Patent O2018212534A1 |
Autotaxin-IN-3
CAS: 2156655-68-2 F: C22H21N9O2 W: 443.46
Autotaxin-IN-3 is a Autotaxin(ATX) inhibitor with an IC50 of 2.4 nM, compound 33, sourced from patent WO2018212534A1.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.